Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Endocannabinoid System Mechanisms The endocannabinoid system (ECS) plays a pivotal role in maintaining homeostasis within the body and has garnered […]
Endocannabinoid System Mechanisms The endocannabinoid system (ECS) plays a pivotal role in maintaining homeostasis within the body and has garnered […]
Study Overview This research investigates the joint therapeutic effect of Akkermansia muciniphila and sodium butyrate on oxaliplatin-induced peripheral neuropathy, a
Study Overview Recent research has highlighted the multifaceted role of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) beyond their primary application
Study Overview The research investigates the discontinuation rates of Angiotensin Converting Enzyme (ACE) inhibitors among Medicare beneficiaries who are concurrently
Endocannabinoid System and Multiple Sclerosis The endocannabinoid system (ECS) consists of a network of receptors, endogenous cannabinoids, and metabolic enzymes
Mechanisms of Action The intervention involving Akkermansia muciniphila and sodium butyrate operates through several interconnected mechanisms that target the underlying
Background and Context Multiple sclerosis (MS) is a chronic autoimmune disease that predominantly affects the central nervous system (CNS), characterized
Case Studies and Observations Recent inquiries into the utilization of the endocannabinoid system for managing residual disease in relapse-free multiple
Study Overview The research investigates the combined effects of Akkermansia muciniphila and sodium butyrate on peripheral neuropathy induced by oxaliplatin,
Tolerating Uncertainty in Diagnosis In the realm of functional motor disorders (FMD), the ambiguity surrounding diagnosis can lead to significant
Tolerating uncertainty to treat functional motor disorder Read Post »